BMO Capital: 'Ingevity Corp (NGVT) Starting to See the Benefits of Past Heavily Lifting'; PT Raised

February 20, 2025 8:07 AM EST Send to a Friend
BMO Capital analyst John McNulty raised the price target on Ingevity Corp (NYSE: NGVT) to $62.00 (from $61.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login